By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Bayer Corporation 

100 Bayer Road

Whippany  New Jersey  07981  U.S.A.
Phone: 1-877-229-3727 Fax:


Bayer: Science For A Better Life

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen.

Bayer’s culture supports its employees through personal development opportunities, international and diverse teams, regular feedback, and state-of-the-art benefits. At Bayer, you have the opportunity to be part of a company where we value the passion of our employees to innovate, and give them the power to change. For further information visit our website at

Key Statistics

Ownership: Subsidiary

Web Site: Bayer
Symbol: BAY

Company News
Bayer (BAY) Appoints Dr. Sharon James Head Of Global Innovation & Development For Consumer Health 9/22/2017 7:22:43 AM
Bayer (BAY) Stops Essure Implant Sales Outside of the U.S. 9/20/2017 6:26:56 AM
Why Bayer (BAY)'s $66 Billion Takeover Of Monsanto (MON) Probably Won't Happen Until 2018 9/19/2017 6:29:29 AM
Bayer (BAY) Receives FDA Approval For Aliqopa (copanlisib) 60 Mg Vial For Injection In Adults With Relapsed Follicular Lymphoma After Two Prior Systemic Therapies 9/15/2017 7:51:42 AM
Bayer (BAY), Ginkgo Bioworks Launch Boston Ag-Tech Firm With $100 Million Series A 9/14/2017 6:16:48 AM
Berkeley Lights Announces Strategic Project With Bayer (BAY) Focused On Cell Line Development And Antibody Discovery 9/12/2017 9:24:42 AM
Bayer (BAY) And Vanderbilt University Medical Center Collaborate To Develop New Therapies Against Kidney Diseases 9/11/2017 8:26:07 AM
Bayer (BAY), 4-H To Grow Tomorrow's Science Leaders 8/30/2017 6:26:07 AM
Bayer (BAY) Announces Enrollment Of First U.S. Patient In Phase III Trials Of Vilaprisan In Uterine Fibroids 8/29/2017 9:00:51 AM
Bayer (BAY) Release: COMPASS Study Presented At ESC Congress 2017 – Largest Rivaroxaban Study To Date, Enrolled 27,395 Patients To Investigate CAD And PAD 8/28/2017 7:53:13 AM